| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 08/02/2001 | US20010010927 A method for screening candidate pesticides using a receptor that binds bacillus thuringiensis toxin |
| 08/02/2001 | US20010010919 Opioid antagonists and methods of their use |
| 08/02/2001 | CA2397998A1 Hiv peptides and nucleic acids encoding them for diagnosis and control of hiv infection |
| 08/02/2001 | CA2397991A1 Diagnosis of tauopathies determining tau/phospho-tau ratio |
| 08/02/2001 | CA2397267A1 Peptide fragments and uses thereof as type-1 interferon antagonist |
| 08/02/2001 | CA2366828A1 Preparation and use of polymers crosslinked with tyrosine-containing peptides |
| 08/01/2001 | EP1120464A2 Stabilizing peptides, polypeptides and antibodies which include them |
| 08/01/2001 | EP1119623A1 Mage-a3 peptides presented by hla class ii molecules |
| 08/01/2001 | EP1119584A1 Peptides related to an igf-ii-r epitope, polynucleotides encoding the peptides, and their use in immunomodulation |
| 08/01/2001 | EP0667897B1 Method for specific immunoassay of human plasmatic glutathione peroxidase |
| 08/01/2001 | EP0656946B1 Immunoglobulins devoid of light chains |
| 08/01/2001 | EP0649434B1 Radioactively-labeled somatostatin-derived peptides for imaging and therapeutic uses |
| 08/01/2001 | CN1306439A Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 07/31/2001 | US6268475 Hexapeptides containing cysteinsulfinic and cysteinesulfenic acid |
| 07/31/2001 | US6268473 Amino acid sequences; muscle relaxants; treating benign essential blepharospasm and other forms of focal dystonia; antiwrinkle agents |
| 07/31/2001 | US6268347 Alleviating neuropathic pain |
| 07/31/2001 | US6268346 Having high biological activity of the same type as the known natural compound bpc, but with shorter amino acid chains. |
| 07/31/2001 | US6268342 Method of inhibiting fibrosis with a somatostatin agonist |
| 07/31/2001 | US6268339 Lanthionine bridged peptides |
| 07/31/2001 | US6268338 Cyclohexapeptidyl amine compounds |
| 07/31/2001 | US6268159 Visualizing tumor cells; administer radioactive particles to humans and detect positioning and accumulation of radioactive particles in body |
| 07/31/2001 | US6267965 Vectors for insertion and expression of foreign genes for use as safe immunization vehicles to elicit immune response against poxvius-ctyomegalovirus and human cytomegalovirus |
| 07/31/2001 | US6267960 Administering monoclonal antibody designated atcc no. hb-12612, hb-12616, atcc no. hb12618, or atcc no. hb-12617 which binds specifically to extracellular domain of prostate stem cell antigen (psca) to inhibit growth of prostate tumor |
| 07/31/2001 | CA2194294C Complexes for use in the diagnosis of vascular diseases |
| 07/26/2001 | WO2001053342A1 Chimeric prostate-homing peptides with pro-apoptotic activity |
| 07/26/2001 | WO2001053336A1 Clostridial toxin derivatives and methods for treating pain |
| 07/26/2001 | WO2001053332A1 Novel substance m-17a and process for producing the same |
| 07/26/2001 | WO2001053331A2 Peptidomimetic modulators of cell adhesion |
| 07/26/2001 | WO2001053330A2 High purity lipopeptides, lipopeptide micelles, processes for preparing same and pharmaceutical compositions containing them |
| 07/26/2001 | WO2001053327A2 Algorithmic design of peptides for binding and/or modulation of the functions of receptors and/or other proteins |
| 07/26/2001 | WO2001053322A2 Aerothricin analogs, their preparation and use |
| 07/26/2001 | WO2001053292A1 Dendrimer precursor dyes for imaging |
| 07/26/2001 | WO2001052900A2 Novel orthogonally protected amino acid chelators for biomedical applications |
| 07/26/2001 | WO2001052880A1 Cyclic peptides as potent and selective melanocortin-4 receptor antagonists |
| 07/26/2001 | WO2001052875A1 Vegf-d/vegf-c/vegf peptidomimetic inhibitor |
| 07/26/2001 | WO2001052746A1 Versatile hydrophilic dyes |
| 07/26/2001 | WO2001052745A1 Novel dyes |
| 07/26/2001 | WO2001001748A3 Peptide compounds that bind her2 |
| 07/26/2001 | WO2000075180A3 Peptides for vaccinating against human cmv |
| 07/26/2001 | US20010009901 Antineoplastic peptides |
| 07/26/2001 | US20010009667 Method of detecting nucleic acid encoding a retrovirus using polymerase chain reaction (pcr) |
| 07/26/2001 | CA2743326A1 High purity lipopeptides, lipopeptide micelles and processes for preparing same |
| 07/26/2001 | CA2396307A1 Cyclic peptides as potent and selective melanocortin-4 receptor antagonists |
| 07/25/2001 | EP1117791A2 Cancer associated antigens and uses therefor |
| 07/25/2001 | EP1117789A2 Synthetic peptides having fgf receptor affinity |
| 07/25/2001 | EP1117775A2 Tissue binding peptides, identification, production and utilization thereof |
| 07/25/2001 | EP1117687A2 Compositions and methods for wt1 specific immunotherapy |
| 07/25/2001 | EP1117682A1 Novel peptides |
| 07/25/2001 | EP1117681A1 Novel peptides |
| 07/25/2001 | EP1117680A2 Ncam binding compounds |
| 07/25/2001 | EP1117679A2 Tumor antigens and ctl clones isolated by a novel procedure |
| 07/25/2001 | EP1117677A1 Ligand presenting assembly (lpa), method of preparation and uses thereof |
| 07/25/2001 | EP0906333B1 Substrates and inhibitors of proteolytic enzymes |
| 07/25/2001 | EP0642357B1 Radiolabelled somatostatin |
| 07/25/2001 | EP0585444B1 Hepatoma treatment with somatostatin analogs |
| 07/25/2001 | CN1305496A Cyclic somatostatin analogs |
| 07/25/2001 | CN1305493A Novel cyclosporins |
| 07/24/2001 | US6265539 Prophylaxis and therapy of acquired immunodeficiency syndrome |
| 07/24/2001 | US6265536 Cyclic hexapeptides having antibiotic activity |
| 07/24/2001 | US6265535 Cyclic peptide; for drug screening of antagonists; antiinflammatory agents; treatment of cachexia, malaria, autoimmune disorders, septic shock, skin allergies, and graft versus host disease |
| 07/24/2001 | US6265380 Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease |
| 07/24/2001 | US6265375 Conformationally constrained backbone cyclized peptide analogs |
| 07/24/2001 | US6265215 Isolated peptides which complex with HLA-Cw16 and uses thereof |
| 07/24/2001 | US6265149 Screening sample for preferential immunological complexes; incubate sample with antigen, incubate sample with control, monitor complexes formed, count complexes in samples, more complexes in antigen sample indicates presence of retrovirus |
| 07/24/2001 | US6264919 Restoring fluorescence; adding biocompatible solvent |
| 07/24/2001 | CA2085465C Thrombin inhibitors based on the amino acid sequence of hirudin |
| 07/24/2001 | CA2065299C Direct radiolabeling of antibodies and other proteins with technetium or rhenium |
| 07/24/2001 | CA2027936C Cyclic anti-aggregatory peptides |
| 07/19/2001 | WO2001051508A1 Peptide inhibitors of lfa-1/icam-1 interaction |
| 07/19/2001 | WO2001051507A1 Novel peptide and screening method by using the same |
| 07/19/2001 | WO2001051506A2 Oligomers of nonpeptide restricted mimetics of dipeptides or tripeptides and the use thereof in the synthesis of synthetic proteins and polypeptides |
| 07/19/2001 | WO2001005811A3 Cyclic peptidomimetic urokinase receptor antagonists |
| 07/19/2001 | WO2001005757A3 Process for the deprotection of protected thiols |
| 07/19/2001 | WO2000069891A3 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins |
| 07/19/2001 | US20010008634 Bactericides, fungicides, insecticides |
| 07/19/2001 | CA2397485A1 Peptide inhibitors of lfa-1/icam-1 interaction |
| 07/19/2001 | CA2396889A1 Novel peptide and screening method by using the same |
| 07/18/2001 | EP1116727A1 Peptide derivative |
| 07/18/2001 | EP1115847A1 Short peptides which selectively modulate the activity of protein kinases |
| 07/18/2001 | EP1115740A1 Synthetic peptides, conjugation reagents and methods |
| 07/18/2001 | EP1115739A1 Auxiliary for amide bond formation |
| 07/18/2001 | EP1115738A1 Synthesis of cyclic peptides |
| 07/18/2001 | EP1115418A2 Aglyco products and methods of use |
| 07/18/2001 | EP1115416A1 Use of substances with oxytocin activity in order to create cell regeneration |
| 07/18/2001 | EP1093458A4 Process for the preparation of resin-bound cyclic peptides |
| 07/17/2001 | US6262264 Redox reversible imidazole osmium complex conjugates |
| 07/17/2001 | US6262027 Reduction of impairment of respiratory tract mucosal immunity |
| 07/17/2001 | US6262021 Wounds of the skin, bone, mucus, tendons, muscles or connective tissue in mammals. |
| 07/17/2001 | US6262017 Peptides for altering osteoblast adhesion |
| 07/17/2001 | US6261804 Selection of proteins using RNA-protein fusions |
| 07/17/2001 | US6261776 Nucleic acid arrays |
| 07/17/2001 | US6261762 Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and the use of these DNA clones polypeptides in diagnostic kits |
| 07/17/2001 | US6261569 Antigens; mixed with carriers; genetic engineering |
| 07/12/2001 | WO2001049713A2 Stabilizing peptides, polypeptides and antibodies which include them |
| 07/12/2001 | WO2001049709A1 Glycogen synthase kinase-3 inhibitors |
| 07/12/2001 | WO2001049708A2 Peptide ligands that mimic sensor kinases and inhibit response regulators |
| 07/12/2001 | WO2001049311A1 Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release |
| 07/12/2001 | WO2001049310A1 C-ski oncogene-derived peptides for prevention, treatment, and diagnosis of cancer |
| 07/12/2001 | WO2001008677A8 Methods of inhibiting osteoclast activity |
| 07/12/2001 | WO2000056144A9 Human sperm surface antigen |